101P Quality of life (QoL) outcomes in patients (pts) with zanidatamab (zani)-treated HER2-positive (HER2+) biliary tract cancer (BTC) in the phase IIb HERIZON-BTC-01 studyHarpreet Wasan, Shubham Pant, Hui‐Chuan Sun et al.|Annals of Oncology|2023Cited by 2